Perceive Biotherapeutics, Inc. is a biopharma and biotechnology startup based in the United States, founded in 2020. The company is focused on developing innovative ophthalmic therapeutics to address significant unmet needs for patients. In a recent milestone, Perceive Biotherapeutics secured a substantial $78.00M Series B investment on 05 January 2023. Notable investors in this round include Catalio Capital Management, Deerfield Management, Braidwell, Retinal Degeneration Fund, and Johnson & Johnson Innovation – JJDC. This latest funding injection is poised to propel Perceive Biotherapeutics towards advancing its research and development efforts, potentially positioning the company as a promising player in the realm of ophthalmic therapeutics.
No recent news or press coverage available for Perceive Biotherapeutics, Inc..